FDG-PET scanning in the diagnosis of gastrointestinal cancers

about

Imaging modalities for characterising focal pancreatic lesions.Diagnostic workup of liver lesions: too long time with too many examinations.

P2860

Q38834240-D4476582-82B6-4039-BB91-3D21D81A2CDC Q53640540-843A0C31-2398-4DD7-BAC9-FC2029D634B3

P2860

FDG-PET scanning in the diagnosis of gastrointestinal cancers

Item

http://www.wikidata.org/entity/Q57779674

description

im Januar 2004 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2004

@uk

name

FDG-PET scanning in the diagnosis of gastrointestinal cancers

@en

FDG-PET scanning in the diagnosis of gastrointestinal cancers

@nl

type

Item

label

FDG-PET scanning in the diagnosis of gastrointestinal cancers

@en

FDG-PET scanning in the diagnosis of gastrointestinal cancers

@nl

prefLabel

FDG-PET scanning in the diagnosis of gastrointestinal cancers

@en

FDG-PET scanning in the diagnosis of gastrointestinal cancers

@nl

P1476

FDG-PET scanning in the diagnosis of gastrointestinal cancers

@en

P2093

F. M. Nagengast

http://www.w3.org/2001/XMLSchema#string

J. B. M. J. Jansen

http://www.w3.org/2001/XMLSchema#string

J. P. H. Drenth

http://www.w3.org/2001/XMLSchema#string

M. C. A. van Kouwen

http://www.w3.org/2001/XMLSchema#string

W. J. G. Oyen

http://www.w3.org/2001/XMLSchema#string

P2860

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group

Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography

Decision analysis for the cost-effective management of recurrent colorectal cancer

Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.

Gastrointestinal stromal tumors: recent advances in understanding of their biology.

Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography

Positron emission tomography for staging of oesophageal and gastroesophageal malignancy

P304

85-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00855920410014614

http://www.w3.org/2001/XMLSchema#string

P433

241

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

diagnosis

FDG-PET scanning in the diagnosis of gastrointestinal cancers

about

P2860

P2860

FDG-PET scanning in the diagnosis of gastrointestinal cancers

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P921